Exane Derivatives’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $525 | Hold |
7
| – | – | ﹤0.01% | 564 |
|
|
2022
Q1 | $557 | Hold |
7
| – | – | ﹤0.01% | 846 |
|
|
2021
Q4 | $568 | Hold |
7
| – | – | ﹤0.01% | 746 |
|
|
2021
Q3 | $542 | Hold |
7
| – | – | ﹤0.01% | 910 |
|
|
2021
Q2 | $559 | Hold |
7
| – | – | ﹤0.01% | 914 |
|
|
2021
Q1 | $552 | Hold |
7
| – | – | ﹤0.01% | 769 |
|
|
2020
Q4 | $500 | Hold |
7
| – | – | ﹤0.01% | 726 |
|
|
2020
Q3 | $447 | Hold |
7
| – | – | ﹤0.01% | 660 |
|
|
2020
Q2 | $453 | Hold |
7
| – | – | ﹤0.01% | 598 |
|
|
2020
Q1 | $385 | Hold |
7
| – | – | ﹤0.01% | 597 |
|
|
2019
Q4 | $462 | Hold |
7
| – | – | ﹤0.01% | 590 |
|
|
2019
Q3 | $397 | Hold |
7
| – | – | ﹤0.01% | 569 |
|
|
2019
Q2 | $421 | Hold |
7
| – | – | ﹤0.01% | 579 |
|
|
2019
Q1 | $456 | Sell |
7
-114
| -94% | -$7.43K | ﹤0.01% | 519 |
|
|
2018
Q4 | $7.54K | Sell |
121
-4,120
| -97% | -$257K | ﹤0.01% | 442 |
|
|
2018
Q3 | $312K | Buy |
+4,241
| New | +$312K | 0.06% | 187 |
|
|
2018
Q2 | – | Sell |
-1,617
| Closed | -$99.7K | – | 661 |
|
|
2018
Q1 | $99.7K | Sell |
1,617
-1,431
| -47% | -$88.3K | 0.02% | 286 |
|
|
2017
Q4 | $196K | Buy |
3,048
+515
| +20% | +$33.2K | 0.03% | 219 |
|
|
2017
Q3 | $166K | Buy |
2,533
+740
| +41% | +$48.4K | 0.03% | 187 |
|
|
2017
Q2 | $113K | Buy |
+1,793
| New | +$113K | 0.02% | 234 |
|
|
2017
Q1 | – | Sell |
-887
| Closed | -$49.7K | – | 598 |
|
|
2016
Q4 | $49.7K | Sell |
887
-735
| -45% | -$41.2K | 0.01% | 269 |
|
|
2016
Q3 | $100K | Buy |
1,622
+73
| +5% | +$4.5K | 0.02% | 217 |
|
|
2016
Q2 | $98.1K | Buy |
1,549
+396
| +34% | +$25.1K | 0.02% | 243 |
|
|
2016
Q1 | $69.3K | Sell |
1,153
-132
| -10% | -$7.93K | 0.01% | 238 |
|
|
2015
Q4 | $89.9K | Buy |
+1,285
| New | +$89.9K | 0.01% | 193 |
|